529 related articles for article (PubMed ID: 8710371)
1. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
Shivakumar CV; Das GC
Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor 1 family members mediate repression of the BK virus late promoter.
Kraus RJ; Shadley L; Mertz JE
Virology; 2001 Aug; 287(1):89-104. PubMed ID: 11504545
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific modulation of the papovavirus promoters by tumor-suppressor protein p53 in the absence of large T-antigen.
Das GC; Shivakumar CV; Todd SD
Oncogene; 1995 Feb; 10(3):449-55. PubMed ID: 7845669
[TBL] [Abstract][Full Text] [Related]
4. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter.
Gorrill TS; Khalili K
Virology; 2005 Apr; 335(1):1-9. PubMed ID: 15823601
[TBL] [Abstract][Full Text] [Related]
5. The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53.
Schmidt T; Körner K; Karsunky H; Korsmeyer S; Müller R; Möröy T
Cell Death Differ; 1999 Sep; 6(9):873-82. PubMed ID: 10510469
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
Pietrzak M; Puzianowska-Kuznicka M
Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
[TBL] [Abstract][Full Text] [Related]
7. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
8. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
Mukhopadhyay T; Roth JA
Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
[TBL] [Abstract][Full Text] [Related]
9. p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Bargonetti J; Chicas A; White D; Prives C
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):935-49. PubMed ID: 9449526
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
12. HPV-18 E6 inhibits p53 DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence.
Thomas M; Massimi P; Banks L
Oncogene; 1996 Aug; 13(3):471-80. PubMed ID: 8760288
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
14. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
Swaminathan S; Thimmapaya B
J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
[TBL] [Abstract][Full Text] [Related]
16. Binding of cellular proteins to a conformational domain of tumor suppressor protein p53.
Maxwell SA; Roth JA
Oncogene; 1993 Dec; 8(12):3421-6. PubMed ID: 8247546
[TBL] [Abstract][Full Text] [Related]
17. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
18. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
19. Analysis of p53 transactivation through high-affinity binding sites.
Chumakov AM; Miller CW; Chen DL; Koeffler HP
Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
[TBL] [Abstract][Full Text] [Related]
20. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
Lou Z; Maher VM; McCormick JJ
Gene; 2005 May; 351():51-9. PubMed ID: 15857802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
